Table 4.
Multivariate analysis of factors influencing DFS and OS.
| Disease-Free Survival | HR (95% CI) | p-Value |
|---|---|---|
|
Histological Type Non-ductal vs. Ductal |
1.90 (0.67–5.44) | 0.228 |
|
Molecular Subtype Luminal B vs. Luminal A |
3.00 (1.00–9.84) | 0.049 |
|
Type of Surgery Mastectomy vs. BCS |
1.96 (0.72–5.38) | 0.188 |
|
Ki67 in Residual Tumor ≥14% vs. <14% |
6.32 (1.27–31.29) | 0.024 |
|
Stage II–III vs. 0–I |
4.52 (0.91–22.42) | 0.064 |
|
Peripheral Markers of Inflammation NLRlow vs. NLRhigh |
5.36 (1.14–25.17) | 0.033 |
| Overall Survival | ||
|
Histological Type Non-ductal vs. Ductal |
2.08 (0.46–9.34) | 0.337 |
|
Type of Surgery Mastectomy vs. BCS |
2.55 (0.59–10.91) | 0.187 |
|
Ki67 in Residual Tumor ≥14% vs. <14% |
7.27 (1.29–40.68) | 0.024 |
|
Peripheral Markers of Inflammation NLRlow vs. NLRhigh |
8.90 (1.08–73.39) | 0.042 |
BCS, breast-conserving surgery.